Journals / European Journal of Breast Health / 2019 / Cilt: 15 - Sayı: 3

Breast Cancer in Turkey; An Analysis of 20.000 Patients with Breast Cancer

Pages
141–146
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

During the mean 51.6 months of follow-up, the local/regional and systemic recurrence rates were 3.7% and5.2%, respectively; five and 10-year overall survival rates were 86% and 76%.Conclusion: Despite increasing number of screening centers and free-of-charge mammography (ages 40 to 69) and mobile screening systems inrecent years, a significant portion of patients were diagnosed at advanced stage due to lack of breast cancer awareness.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Breast cancer is the most common type of cancer and the leading cause of cancer-related deaths in women in Turkey.
📊
Key Findings & Data:This study presentsthe characteristics of patients registered in National Breast Cancer Registry Program of Turkish Federation of Breast Diseases Societies.Materials and Methods: The registry contains 242 variables under 10 categories and 699 questions.
💡
Conclusion & Impact:During the mean 51.6 months of follow-up, the local/regional and systemic recurrence rates were 3.7% and5.2%, respectively; five and 10-year overall survival rates were 86% and 76%.Conclusion: Despite increasing number of screening centers and free-of-charge mammography (ages 40 to 69) and mobile screening systems inrecent years, a significant portion of patients were diagnosed at advanced stage due to lack of breast cancer awareness.
🔬Design:Research Article
📍Scope:2005 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: Breast cancer is the most common type of cancer and the leading cause of cancer-related deaths in women in Turkey. This study presentsthe characteristics of patients registered in National Breast Cancer Registry Program of Turkish Federation of Breast Diseases Societies.Materials and Methods: The registry contains 242 variables under 10 categories and 699 questions. Patients were recorded (online and offline)from nationwide breast centers around Turkey.Results: Twenty-thousand patients were registered between May 2005 and April 2017 at 36 centers. After data cleaning, 19,503 women wereincluded in the study. The median age at diagnosis was 51 [14-97]; 17.2% were younger than 40 and 37.2% were premenopausal; 13.6% werenulliparous. Breast conserving surgery rate was 39.3%. Histopathology was invasive ductal cancer in 77%. Majority of patients had stage II cancer(48.3%). Estrogen, progesterone and HER-2 receptor positivity rates in invasive breast cancer were 72.5%, 62.5% and 21.8%, respectively. Themean tumor diameter was 2.5±1.7 cm. During the mean 51.6 months of follow-up, the local/regional and systemic recurrence rates were 3.7% and5.2%, respectively; five and 10-year overall survival rates were 86% and 76%.Conclusion: Despite increasing number of screening centers and free-of-charge mammography (ages 40 to 69) and mobile screening systems inrecent years, a significant portion of patients were diagnosed at advanced stage due to lack of breast cancer awareness. In contrast with the studypublished 5 years ago, there was a decrease in the rate of pre-menopausal women and an increase in the breast conserving surgery.

🔖

Cite This Article

ÖZMEN, T., DOĞRU, V., ÖZMEN, V. (2022). Breast Cancer in Turkey; An Analysis of 20.000 Patients with Breast Cancer. European Journal of Breast Health, Cilt: 15 - Sayı: 3, 141–146. https://ajindex.com/articles/650421

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018
  2. (PMID: 30207593) [CrossRef] 2. Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Piñeros M, Znaor A, Bray F. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer 2019
  3. (PMID: 30350310) [CrossRef] 3. Ozmen V. Breast Cancer in Turkey: Clinical and Histopathological Characteristics (Analysis of 13.240 Patients). J Breast Health 2014
  4. (PMID: 28331652) [CrossRef] 4. Ozmen V, Boylu S, Ok E, Canturk NZ, Celik V, Kapkac M, Girgin S, Tireli M, Ihtiyar E, Demircan O, Baskan MS, Koyuncu A, Tasdelen I, Dumanli E, Ozdener F, Zaborek P. Factors affecting breast cancer treatment delay in Turkey: a study from Turkish Federation of Breast Diseases Societies. Eur J Public Health 2015
  5. (PMID: 25096257) [CrossRef] 5. Bloom HJ, Richardson WW. Histological grading and prognosis in breast cancer
  6. a study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer 1957
  7. (PMID: 1349978) [CrossRef] 6. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 1991
  8. (PMID: 1757079) [CrossRef] 7. DeSantis CE, Bray F, Ferlay J, Lortet-Tieulent J, Anderson BO, Jemal A. International Variation in Female Breast Cancer Incidence and Mortality Rates. Cancer Epidemiol Biomarkers Prev 2015
  9. (PMID: 26359465) [CrossRef] 8. Porter P. "Westernizing" women's risks? Breast cancer in lower-income countries. N Engl J Med 2008
  10. (PMID: 18199859) [CrossRef] 9. Ries LG, Pollack ES, Young JL Jr. Cancer patient survival: Surveillance, Epidemiology, and End Results Program, 1973-79. J Natl Cancer Inst 1983
  11. (PMID: 6572758) 10. European Commission. European Network of Cancer Registries. Luxembourg, Office for Official Publications of the European Communities, 1995. 11. Tuncer M, Özgül N, Olcayto EÖ, Gültekin M, Erdin B. Ulusal Kanser Programı 2009-2015, T.C. Sağlık Bakanlığı Kanserle Savaş Dairesi başkanlığı 2009: ISBN 978-975-590-285-2. 12. Noone AM, Howlader N, Krapcho M, Miller D, Brest A, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds)